ICIs block co-inhibitory signals, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death-1 and programmed death-ligand 1 (PD-1 and PD-L1) axis, to trigger immune responses and eradicate cancer cells [5]. Here, CTLA4 is linked to cancer.